Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen
Biogen
FDA grew too close to Biogen during Alzheimer’s drug development, doctors say
Pharmaforum
Thu, 04/1/21 - 10:51 am
FDA
Biogen
drug development
aducanumab
Alzheimer's disease
FDA advisers reassert case against approval of Biogen's Alzheimer's drug
BioPharma Dive
Wed, 03/31/21 - 10:55 pm
Biogen
FDA
Alzheimer's disease
aducanumab
5 FDA approval decisions to watch in the second quarter
BioPharma Dive
Mon, 03/29/21 - 11:16 pm
FDA
Biogen
aducanumab
Acadia Pharmaceuticals
pimavanserin
AstraZeneca
vaccines
COVID-19
Sanofi
Avalglucosidase alfa
Pfizer
pneumococcal disease
Biogen's Aducanumab: A Look at the Drug’s History and Recent Updates
BioSpace
Sat, 03/27/21 - 12:14 pm
Biogen
Eisai
aducanumab
Alzheimer's disease
Big pharma’s key catalysts in the second quarter
EP Vantage
Wed, 03/24/21 - 10:04 am
Biogen
Alzheimer's disease
aducanumab
Sanofi
breast cancer
FDA
Biogen outlines 10M-patient opportunity for Alzheimer's drug in US
Biopharma Reporter
Tue, 03/16/21 - 10:48 pm
Biogen
Alzheimer's disease
aducanumab
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Tue, 03/9/21 - 10:45 am
Clarivate
Biogen
Eisai
aducanumab
UCB Pharma
bimekizumab
Relugolix
Pfizer
Takeda
Myovant
vericiguat
Bayer
Merck
Biogen to build gene therapy manufacturing center in North Carolina
Marketwatch
Thu, 03/4/21 - 09:50 am
Biogen
gene therapy
North Carolina
drug manufacturing
RTP
Where Will Biogen Be in 5 Years?
Motley Fool
Tue, 02/23/21 - 10:40 am
Biogen
aducanumab
Alzheimer's disease
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharmaforum
Fri, 02/19/21 - 10:33 am
pharma industry
R&D
pandemic
earnings
COVID-19
Biogen
GW Pharma
Jazz Pharmaceuticals
GSK
Merck KGaA
A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice
Fierce Biotech
Thu, 02/18/21 - 11:04 am
Alzheimer's disease
Denali Therapeutics
Biogen
aducanumab
HAE-4
Former Biogen CEO Takes the Helm at Editas Medicine
BioSpace
Mon, 02/8/21 - 10:25 pm
Biogen
Editas Medicine
James Mullen
Pharma CEOs
Biogen laser-focused on Alzheimer's drug as rest of business falters
BioPharma Dive
Wed, 02/3/21 - 10:55 pm
Biogen
earnings
aducanumab
Alzheimer's disease
Biogen tosses out Parkinson's hopeful cinpanemab, pays $75M for its syn
Fierce Biotech
Wed, 02/3/21 - 10:53 am
Biogen
earnings
Parkinson's Disease
cinpanemab
FDA extends review period for Biogen's Alzheimer's drug
Reuters
Fri, 01/29/21 - 10:06 am
Biogen
Eisai
FDA
aducanumab
Alzheimer's disease
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
drug launches
Biogen
Eisai
aducanumab
efgartigimod
Argenx
Evrenzo
FibroGen
Astellas
AstraZeneca
Leqvio
Novartis
UCB Pharma
bimekizumab
Ascendis Pharma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
liso-cel
AXS-05
Axsome Therapeutics
voclosporin
Aurinia
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
Here's the Top FDA Decision to Watch in 2021
Motley Fool
Sun, 01/17/21 - 04:56 pm
FDA
Biogen
aducanumab
Alzheimer's disease
JPM21: Biogen faces make-or-break year, Vertex mulls deals and Sarepta pitches a silver lining
BioPharma Dive
Mon, 01/11/21 - 07:06 pm
JPMHC 2021
Biogen
Vertex Pharmaceuticals
Sarepta Therapeutics
Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling
Fierce Biotech
Mon, 01/11/21 - 10:30 am
Atalanta Therapeutics
Biogen
Genentech
F-Prime
neurodegenerative disease
Pages
« first
‹ previous
…
18
19
20
21
22
23
24
25
26
…
next ›
last »